Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
14,536 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Genetic drivers of etiologic heterogeneity in thyroid cancer.
Jee YH, Pozdeyev N, Gignoux CR, White S, Haugen BR, Verma A, Peculis R, Rovite V, Mulford AJ, Sanders AR, Kitahara CM, Reeve MP, Kraft P, Martin AR. · Nat Commun · 2026 · cited 0 timesOpen accessmeta-analysis, research support, n.i.h., extramural
- [Clinical exploration of near-infrared autofluorescence imaging for parathyroid gland preservation in thyroid cancer surgery].
Huang C, He J, Hu P, Ding K, Qi X. · Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2026 · cited 0 timesrandomized controlled trial, english abstract
- Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Bondet de La Bernardie S, Bernier MO, Buffet C, Lussey-Lepoutre C, Baudin C. · Eur Thyroid J · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Efficacy of iodine-125 seed implantation for differentiated thyroid cancer: a time-stratified systematic review and meta-analysis of comparative and single-arm studies.
Pan XH, Ma LB, Han HT, Zhao YX, Yang Z. · Endocrine · 2026 · cited 0 timesmeta-analysis, comparative study
- Dietary Pattern and Risk of Thyroid Cancer: A Systematic Review.
Nagashima YG, Soares AA, Piuvezam G, Alves CX, Medeiros KS, Brandão-Neto J, Lopes MMGD. · J Hum Nutr Diet · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Reassessing Radioactive Iodine Use After Thyroidectomy in Low-Risk Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.
Asif M, Nisar M, Asif A, Batool M, Iqbal RJ, Amin MHJ. · Endocrinol Diabetes Metab · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- The diagnosis and management of ectopic thyroid cancer: a systematic review.
Quan M, Tao X, Tang J, Chen H, Liu Q, Li Q, Li J, Wang X, Liao W, Li C, Zhang S, Zhao Y. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Mutations of the DICER1 gene among children and adolescents with thyroid cancer: a systematic review.
Dimaki A, Kotanidou EP, Tsinopoulou VR, Dimakis IK, Tragiannidis A, Hatzipantelis E, Galli-Tsinopoulou A. · Pediatr Res · 2026 · cited 0 timessystematic review
- Efficacy of redifferentiation therapy in radioactive iodine refractory thyroid cancer: a systematic review and meta-analysis.
Zampella E, Cantoni V, Green R, Gaudieri V, Volpicelli F, Piscopo L, Scaglione M, Cuocolo A, Klain M. · Eur J Nucl Med Mol Imaging · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Meta-analysis and systematic review: the association between rheumatoid arthritis and the risk of thyroid cancer.
Li X, Liu R, Zhang Y, Li J, Wang X, Wang C, Yang X. · Front Immunol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Neoadjuvant anlotinib for locally advanced thyroid cancer: a single-arm phase II study (ALTER-T001).
Li D, Yang A, Wang Z, Ge M, Zheng X, Wei S, Qin J, Wang S, Fan Y, Chen S, Chen Y, Huang N, Tan Z, Zhou B, Wang S, Wang Y, Gao M. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accessclinical trial, phase ii
- Predictors of thyroid cancer in paediatric patients with thyroid nodules: A systematic review and meta-analysis.
Shah S, Walters B, Balasubramanian SP, Edafe O. · Eur Arch Otorhinolaryngol · 2026 · cited 0 timesmeta-analysis, systematic review
- Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis.
Piccardo A, Fiz F, Bottoni G, Treglia G, Trimboli P. · Eur Thyroid J · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Sequential therapy with anlotinib and radioiodine for distant metastatic differentiated thyroid cancer: a phase II clinical trial.
Song H, Shen C, Fan Y, Liu Z, Wang Y, Luo Q, Chen L. · Oncologist · 2026 · cited 0 timesOpen accessclinical trial, phase ii
- Thyroid cancer risk in people living with HIV: a systematic review and meta-analysis of global population-based registry studies.
Xia Q, Jiang Y, Sun C, Xu J. · Eur Arch Otorhinolaryngol · 2026 · cited 0 timesmeta-analysis, systematic review
- Thyroid Cancer Management in Contemporary Practice: A Systematic Review and Meta-Analysis of Diagnostic Pathways, Surgical Strategies, Airway Challenges, and Mediastinal Extension.
Koraitim AFI, Mohamed MM, Alwaseef MAE, Mawkili A, Abdesalam HA, Abu Halimah JH, Allam KA, Ibrahim AAAM, Ibrahim HSE, Abdelaziz SMME, Abdalgaleel MA, Barakat M, Bukas SG, Omar A, Mobasher MA. · Clin Ter · 2026 · cited 0 timesmeta-analysis, systematic review
- Return to Work and Employment Outcomes in Survivors of Differentiated Thyroid Cancer: A Systematic Review.
Sirbu AM, Oancea C, Sirbu OM, Cernamoriti A, Paun DL. · J Occup Rehabil · 2026 · cited 0 timessystematic review
- Diagnostic accuracy and association with lymph node metastasis of the systemic immune-inflammation index in thyroid cancer: a systematic review and meta-analysis.
Dragota RS, Schenker M, Ciurea AM, Turcu-Stiolica A, Popescu M, Stanculescu A, Ungureanu BS, Ciurea T. · Front Immunol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Metabolic syndrome and incident thyroid cancer risk in adults: A systematic review and meta-analysis.
He Z, Zhou J, Lu X. · Biomol Biomed · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Association between infertility and thyroid cancer risk: a systematic review and meta-analysis.
Qiao X, Tian X, Zhou W, Qin Z, Yu J. · Front Oncol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Visualizing research on the prognosis of papillary thyroid cancer: a bibliometric analysis.
Wang P, Wang MJ, Mao QF, Han SB, Liu W, Zhao CQ, Zhou C. · Front Oncol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.
Sugitani I, Kiyota N, Imai H, Takahashi S, Nishiyama A, Tamura S, Shimizu Y, Kadowaki S, Ito KI, Hirashima Y, Ueno S, Katayama T, Tahara M. · Int J Clin Oncol · 2026 · cited 0 timesOpen accessclinical trial, phase ii, multicenter study
- Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer.
Turaga AH, Finnerty BM, Zarnegar R, Fahey TJ. · Crit Rev Oncol Hematol · 2026 · cited 0 timessystematic review
- Pembrolizumab in recurrent or metastatic medullary thyroid cancer.
Del Rivero J, Donahue RN, Marte JL, Gramza A, Cordes L, Karzai F, Abel ML, Schlom J, Gulley JL, Madan RA. · Oncologist · 2025 · cited 1 timesclinical trial, phase ii, randomized controlled trial
- Efficacy of Sapylin in endoscopic thyroid cancer surgery: a double-blind, randomized, controlled trial.
Chen Y, Wang S, Bin B, Huang M, Huang J. · Surg Endosc · 2026 · cited 0 timesrandomized controlled trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.